Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-02-14
1993-03-23
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514285, 514396, 514401, A61K 31505, A61K 3144, A61K 31415
Patent
active
051964325
ABSTRACT:
Ruminal lactic acidosis develops in ruminant animals following the ingestion of large amounts of unaccustomed feeds that are rich in readily fermentable carbohydrates. Characteristics symptoms of this disease include systemic acidosis, ruminal acidosis, forestomach stasis or forestomach hypomotility, inappetence, depression and hemoconcentration. Alpha-2 adrenoceptor antagonists have been found to be capable of re-establishing forestomach motility that has been lost or severely diminished in ruminants suffering from ruminal lactic acidosis. These antagonist compounds have also been found to be effective in the treatment of ruminants experiencing ruminal lactic acidosis.
REFERENCES:
patent: 2161938 (1939-06-01), Sonn
patent: 4112069 (1978-09-01), Huber
patent: 4172127 (1979-10-01), Huber
patent: 4359474 (1982-11-01), Anderson et al.
patent: 4454139 (1984-06-01), Ward et al.
patent: 4473572 (1984-09-01), Ward
patent: 4481200 (1984-11-01), Ward et al.
patent: 4526967 (1985-07-01), Ward
patent: 4550114 (1985-10-01), White
patent: 4604398 (1986-08-01), Ward
patent: 4616017 (1986-10-01), Baldwin et al.
patent: 4640916 (1987-02-01), Mequro et al.
patent: 4640924 (1987-02-01), White et al.
patent: 4652642 (1987-03-01), De Marinis
patent: 4683229 (1987-07-01), Demarinis et al.
patent: 4686226 (1987-08-01), Huff et al.
patent: 4689339 (1987-08-01), Karjalainen et al.
patent: 4690928 (1987-09-01), Huff et al.
patent: 4704382 (1987-11-01), Chorvat et al.
patent: 4710504 (1987-12-01), Baldwin et al.
patent: 4717731 (1988-01-01), White et al.
patent: 4738979 (1988-04-01), Calderan et al.
patent: 4788202 (1988-11-01), Ward
Chemical Abstracts (108:15047w) 1988.
Chemical Abstracts (110: 16970t) 1989.
Chemical Abstracts (111: 90310p) 1989.
Chemical Abstracts (110: 18409q) 1988.
Chemical Abstracts (106: 96101q) 1986.
Chemical Abstracts (105: 35481w) 1986.
Chemical Abstracts (102: 160313g) 1984.
Nicholson et al., "Inhibition of Rumination in Sheep by .alpha.-Adrenoreceptor Antagonists", J. Vet. Pharmacol. Therap. 11:276-282 (1988).
Ruckebusch, "Pharmacology of Reticulo-Ruminal Motor Function", J. Vet. Pharmacol. Therap. 6:245-272 (1983).
Ruckebusch et al., "Depression of Reticulo-Ruminal Motor Functions Through the Stimulation of .alpha..sub.2 -Adrenoceptors", J. Vet. Pharmacol. Therap. 10:1-10 (1987).
Bueno et al., "Influence of Dopamine on Rumino-Reticular Motility and Rumination in Sheep", J. Vet. Pharmacol. Therap. 6: 93 (1983).
Toutain et al., "Assessment of Alpha-2 Adrenergic Antagonists on the Central Nervous System Using Reticular Contraction in Sheep as a Model", J. Pharmacol. Exp. Therap. 223: 215-218 (1982).
Ruckebusch et al., "Specific Antagonism of Xylazine Effects on Reticulo-Rumen Motor Function in Cattle", Veterinary Med. Review, 1: 3-12 (1984).
T. J. Hopkins, "The Clinical Pharmacology of Xylazine in Cattle", Australian Veterinary Journal, 48: 109-112 (1972).
Waddell Frederick E.
Weddington K.
LandOfFree
Mechanism mediating ruminal stasis in ruminal lactic acidosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mechanism mediating ruminal stasis in ruminal lactic acidosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mechanism mediating ruminal stasis in ruminal lactic acidosis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1351880